AN2 Therapeutics
broad activity in activity against clinical isolates of mac with between to range activity of and against isolates of mac including isolates isolates complex is a generic used to treat patients with mac lung disease and is the only currently approved therapy for the treatment of mac lung disease an therapeutics | AN2 Therapeutics
Deck Type
IPO
Deck date
March 2022
Slide
15 of 27
Similar slides by AN2 Therapeutics
Investor Presentation
August 2022
Other recent decks by AN2 Therapeutics
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io